Characteristics of persistent depression in the long-term: Randomized controlled trial and two-year observational study

被引:0
|
作者
Koshikawa, Yosuke [1 ]
Onohara, Ai [2 ]
Wakeno, Masataka [1 ]
Takekita, Yoshiteru [1 ]
Kinoshita, Toshihiko [1 ]
Kato, Masaki [1 ]
机构
[1] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan
[2] Social Welf Corp Uminoko Gakuen Ikejimaryo, Osaka, Japan
基金
日本学术振兴会;
关键词
Persistent depressive disorder; Work and activities; General somatic symptoms; Insight; change the diagnosis to bipolar; major depressive disorder; NATIONAL EPIDEMIOLOGIC SURVEY; WEEKLY SYMPTOMATIC STATUS; CLINICAL FACTORS; NATURAL-HISTORY; RISK-FACTORS; DISORDER; ASSOCIATION; RESISTANCE; ALCOHOL; ANXIETY;
D O I
10.1016/j.heliyon.2023.e20917
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Major depressive disorder is a chronic condition that can recur and relapse. It would be clinically useful to know the patient background to predict the chronicity of depressive symptoms, and the change in diagnosis of bipolar disorder. This study included 197 patients enrolled in a six-week randomized controlled trial with a two-year follow-up. We conducted multiple logistic regression analyses to identify the clinical and sociodemographic characteristics associated with persistent depressive disorder (PDD), relapse, and changes in bipolar disorder diagnosis. The significantly correlated factors were residual symptoms, including insight, work and activity, and general somatic symptoms at week six. We could not identify any factors that contributed to relapse or change in the diagnosis of bipolar disorder. We found that the specific residual symptoms of acute treatment affected long-term treatment outcomes for depression. Attention should be paid to the residual symptoms of depression in the early stages of treatment, and measures should be considered to improve them. There are several limitations to this study, including the fact that PDD may exist among patients who discontinued treatment, treatment was not standardized during the study period, and adherence was confirmed verbally.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Long-Term Results of a Randomized Controlled Trial in Childhood IgA Nephropathy
    Kamei, Koichi
    Nakanishi, Koichi
    Ito, Shuichi
    Saito, Mari
    Sako, Mayumi
    Ishikura, Kenji
    Hataya, Hiroshi
    Honda, Masataka
    Iijima, Kazumoto
    Yoshikawa, Norishige
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06): : 1301 - 1307
  • [42] A CONTROLLED RANDOMIZED TRIAL OF ATYPICAL DEPRESSION - STUDY DESIGN AND PATIENT CHARACTERISTICS
    JARRETT, RB
    SCHAFFER, MH
    DOWN, MM
    CHENG, QC
    JUDD, C
    MCINTIRE, D
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 617 - 617
  • [43] TWO-YEAR RESULTS FOR THE OBSERVATIONAL STUDY OF OSTOMY CONSUMERS
    Malandrino, Renee
    Riemer, Michael
    Urwin, Sally
    Salvadalena, Ginger
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2021, 48 : S44 - S45
  • [44] Randomized controlled trial of lifestyle activity for long-term weight control
    Wadden, T
    Foster, G
    Sargent, S
    Fonshell, K
    Hesson, L
    Walker, K
    Byrne, K
    Berkowitz, R
    Verde, T
    Jakicic, J
    OBESITY RESEARCH, 2004, 12 : A51 - A52
  • [45] THE RANDOMIZED CONTROLLED TRIAL IN THE LONG-TERM CARE SETTING - RECRUITMENT AND ENROLLMENT
    MONANE, M
    GURWITZ, J
    AVORN, J
    LIPSITZ, L
    COULOMBRE, J
    BASTIANELLI, T
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (08) : A51 - A51
  • [46] LONG-TERM OUTCOMES OF ENHANCED DEPRESSION TREATMENT IN PATIENTS WITH ACUTE CORONARY SYNDROMES: THE COPES RANDOMIZED CONTROLLED TRIAL
    Ye, Siqin
    Shaffer, Jonathan
    Rieckmann, Nina
    Schwartz, Joseph
    Kronish, Ian M.
    Ladapo, Joseph A.
    Whang, William
    Burg, Matthew
    Davidson, Karina
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E200 - E200
  • [47] Two-year Randomized, Controlled Clinical Trial of a Flowable and Conventional Composite in Class I Restorations
    Lawson, N. C.
    Radhakrishnan, R.
    Givan, D. A.
    Ramp, L. C.
    Burgess, J. O.
    OPERATIVE DENTISTRY, 2015, 40 (06) : 594 - 602
  • [48] Soy isoflavone (IF) supplementation appears safe after a two-year randomized controlled trial (RCT)
    Steinberg, Francene
    Murray, Michael
    Lewis, Richard
    Cramer, Margaret
    Amato, Paula
    Young, Ronald
    Barnes, Stephen
    Fraley, Kennard
    Konzlemann, Karen
    Smith, E. O.
    Fischer, Joan
    Wong, William
    FASEB JOURNAL, 2008, 22
  • [49] Two-Year Observational Study of Deferiprone in Superficial Siderosis
    Kessler, Remi
    Schwartz, Kateryna
    Li, Xu
    Mealy, Maureen
    Levy, Michael
    NEUROLOGY, 2017, 88
  • [50] The long-term effects of ABM on symptom severity in patients with recurrent depression: A randomized sham-controlled trial
    Bo, Ragnhild
    Kraft, Brage
    Jonassen, Rune
    Pedersen, Mads Lund
    Harmer, Catherine J.
    Landro, Nils Inge
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 340 : 886 - 892